|
Allergic rhinitis and the patient with Asthma |
|
|
A guide for health professionals
Contents
PDF Version
Allergic rhinitis and the patient with Asthma: A guide for health professionals 249.65 Kb
Summary of evidence
-
Effective treatment of allergic rhinitis improves asthma control and lung function. <Level II>
-
Measures that have consistently been reported effective in reducing mite exposure include hot (>55 degrees C) washing of all bedding and the use of mite-proof cases for mattresses and pillows. <Level II>
-
Intranasal corticosteroids are more effective than antihistamines in controlling symptoms of allergic rhinitis as well as non-allergic rhinitis. <Level I>
-
Long-term use of newer intranasal corticosteroids does not appear to affect the hypothalamic–pituitary–adrenal (HPA) axis or cause mucosal atrophy. <Level II>
-
Specific allergen immunotherapy is effective in the management of rhinitis and asthma and can achieve a durable remission of allergic symptoms. <Level I>
-
Specific allergen immunotherapy may reduce the risk of childhood rhinitis progressing to asthma. <Level II>
Note
This information paper is intended to provide information on the clinical interrelationship between asthma and allergic rhinitis for GPs, asthma educators, practice nurses and pharmacists. For more information on the diagnosis and management of allergic rhinitis in primary care, see: Australasian Society of Clinical Immunology and Allergy. Asthma and Allergy. Australian Government Department of Health and Ageing 2005 (available at: www.nationalasthma.org.au).
Acknowledgements
This brochure has been proudly sponsored by
National Asthma Council Australia
ABN 61 058 044 634
Suite 104, Level 1
153-161 Park Street
South Melbourne VIC 3205
Australia
Tel: 03 9929 4333
Fax: 03 9929 4300
Email:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
www.nationalasthma.org.au September 2006
Disclaimer
Although all care has been taken, this information paper is a general guide only which is not intended to be a substitute for individual medical advice/treatment. The National Asthma Council expressly disclaims all responsibility (including for negligence) for any loss, damage or personal injury resulting from reliance on the information contained.
Content Updated September 2006
|
|
Last Updated ( Thursday, 23 April 2009 )
|